FASTER, PLEASE: SCIPIO Trial Shows Cardiac Stem Cell Benefits for Heart Failure Patients. “Heart failure patients with a previous myocardial infarction showed an average of 12 percent improvement one year following an investigative treatment that infused them with their own stem cells. The results triple the 4 percent improvement average the researchers projected for the Phase I trial. Results of the trial have been published in The Lancet and concurrently presented at the American Heart Association Scientific Sessions in Orlando, Fla. They are the first report of administering subjects’ own cardiac stem cells in humans. Previous studies have used stem cells harvested from bone marrow.”
I’m surprised this hasn’t gotten more attention.